Saturday 17 October 2026
Export MIRA’s income statement to Excel — free account
MIRA Pharmaceuticals, Inc.
MIRA Healthcare Drug Manufacturers General
In the quarter to June 2026, EPS grew 66.7% and free cash flow fell 50.8%, each against the same quarter a year earlier.
0.63
0.03
−4.55%
Follow MIRA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (710.85%) | (589.40%) | (508.28%) | (510.93%) |
+8 more TTM periods Free account |
|
| (684.27%) | (577.42%) | (456.59%) | (477.58%) | ||
ROIC |
(12,016.10%) | 0.00% | 0.00% | (32,898.61%) | |
Return on Tangible Assets |
(381.90%) | (336.78%) | (308.99%) | (378.18%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.11) | (0.10) | (0.20) | (0.28) | |
Free Cash Flow |
(4.64) | (4.23) | (4.66) | (5.33) | |
| Other line items | |||||
Cash ROIC |
(28.50%) | (22.57%) | (21.76%) | (35.34%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.15 | 0.14 | 0.15 | 0.19 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.11) | (0.10) | (0.20) | (0.28) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates